Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11576879rdf:typepubmed:Citationlld:pubmed
pubmed-article:11576879lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:11576879lifeskim:mentionsumls-concept:C0017658lld:lifeskim
pubmed-article:11576879lifeskim:mentionsumls-concept:C1969372lld:lifeskim
pubmed-article:11576879lifeskim:mentionsumls-concept:C0332208lld:lifeskim
pubmed-article:11576879lifeskim:mentionsumls-concept:C0205329lld:lifeskim
pubmed-article:11576879lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:11576879lifeskim:mentionsumls-concept:C0443172lld:lifeskim
pubmed-article:11576879pubmed:issue4lld:pubmed
pubmed-article:11576879pubmed:dateCreated2001-9-28lld:pubmed
pubmed-article:11576879pubmed:abstractTextThere is much debate over the origins of fibroblast-type cells that accumulate in interstitial fibrosis. A controversial hypothesis, supported by data from animal and cell-culture studies, is that fibroblast-type cells can derive from tubular epithelial cells by a process of epithelial-mesenchymal transdifferentiation. However, to date, no evidence supports this postulate in human glomerulonephritis. This study sought to provide evidence that tubular epithelial cells can undergo phenotypic change toward a fibroblast-like cell in human glomerulonephritis. One hundred twenty-seven open renal biopsy specimens from patients with minimal change disease (MCD), immunoglobulin A (IgA) nephropathy, and rapidly progressive glomerulonephritis (RPGN) were examined for tubular phenotypic change by two-color immunohistochemistry using the criteria of de novo expression of alpha-smooth muscle actin (alpha-SMA), a myofibroblast marker; loss of the epithelial marker cytokeratin; and collagen production. In normal human kidney and MCD, tubular epithelial cells expressed cytokeratin with no evidence of alpha-SMA staining. However, in 36 of 90 cases of IgA nephropathy and 9 of 18 cases of RPGN, small numbers of tubular epithelial cells in areas of fibrosis showed de novo alpha-SMA expression, accounting for 0.4% +/- 0.2% (IgA nephropathy) and 3.8% +/- 1.5% (RPGN) of cortical tubules. An intermediate stage of phenotypic change was observed in some cuboidal epithelial cells that expressed both cytokeratin and alpha-SMA. Tubules containing alpha-SMA-positive (alpha-SMA(+)) cells also stained for collagen types I and III, suggesting that tubular cells undergoing phenotypic change have an active role in the fibrotic process. There also was a marked increase in transforming growth factor-beta1 (TGF-beta1) tubular expression in areas with interstitial fibrosis, including tubules with phenotypic change. There was a highly significant correlation between tubular alpha-SMA expression and interstitial fibrosis, interstitial alpha-SMA(+) myofibroblast accumulation, deposition of collagen types I and III, tubular TGF-beta1 expression, and renal dysfunction. In conclusion, this study provides evidence that tubular epithelial cells can undergo phenotypic change toward a myofibroblast-like phenotype on the basis of de novo alpha-SMA expression, loss of cytokeratin, and de novo collagen staining. These data, although not conclusive, provide the first support for the hypothesis that transdifferentiation of tubular epithelial cells has a role in progressive renal fibrosis in human glomerulonephritis.lld:pubmed
pubmed-article:11576879pubmed:languageenglld:pubmed
pubmed-article:11576879pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11576879pubmed:citationSubsetIMlld:pubmed
pubmed-article:11576879pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11576879pubmed:statusMEDLINElld:pubmed
pubmed-article:11576879pubmed:monthOctlld:pubmed
pubmed-article:11576879pubmed:issn1523-6838lld:pubmed
pubmed-article:11576879pubmed:authorpubmed-author:KurokawaKKlld:pubmed
pubmed-article:11576879pubmed:authorpubmed-author:AtkinsR CRClld:pubmed
pubmed-article:11576879pubmed:authorpubmed-author:SakaiHHlld:pubmed
pubmed-article:11576879pubmed:authorpubmed-author:CHIT HTHlld:pubmed
pubmed-article:11576879pubmed:authorpubmed-author:Nikolic-Pater...lld:pubmed
pubmed-article:11576879pubmed:authorpubmed-author:HuangX RXRlld:pubmed
pubmed-article:11576879pubmed:authorpubmed-author:JindoAAlld:pubmed
pubmed-article:11576879pubmed:issnTypeElectroniclld:pubmed
pubmed-article:11576879pubmed:volume38lld:pubmed
pubmed-article:11576879pubmed:ownerNLMlld:pubmed
pubmed-article:11576879pubmed:authorsCompleteYlld:pubmed
pubmed-article:11576879pubmed:pagination761-9lld:pubmed
pubmed-article:11576879pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11576879pubmed:meshHeadingpubmed-meshheading:11576879...lld:pubmed
pubmed-article:11576879pubmed:meshHeadingpubmed-meshheading:11576879...lld:pubmed
pubmed-article:11576879pubmed:meshHeadingpubmed-meshheading:11576879...lld:pubmed
pubmed-article:11576879pubmed:meshHeadingpubmed-meshheading:11576879...lld:pubmed
pubmed-article:11576879pubmed:meshHeadingpubmed-meshheading:11576879...lld:pubmed
pubmed-article:11576879pubmed:meshHeadingpubmed-meshheading:11576879...lld:pubmed
pubmed-article:11576879pubmed:meshHeadingpubmed-meshheading:11576879...lld:pubmed
pubmed-article:11576879pubmed:meshHeadingpubmed-meshheading:11576879...lld:pubmed
pubmed-article:11576879pubmed:meshHeadingpubmed-meshheading:11576879...lld:pubmed
pubmed-article:11576879pubmed:year2001lld:pubmed
pubmed-article:11576879pubmed:articleTitleTubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis.lld:pubmed
pubmed-article:11576879pubmed:affiliationDepartment of Nephrology, Tokai University School of Medicine, Isehara, Japan.lld:pubmed
pubmed-article:11576879pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11576879pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11576879lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11576879lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11576879lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11576879lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11576879lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11576879lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11576879lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11576879lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11576879lld:pubmed